Reveleer Strengthens Portfolio with Novillus Acquisition

Reveleer, the leading value-based care technology platform, has announced its acquisition of Novillus, a company that provides insight-driven care gap management and provider engagement solutions. This strategic move is a response to the healthcare industry's increasing emphasis on value-based care and aligns with the growing importance of Medicare Advantage's Star ratings. By purchasing Novillus, Reveleer aims to augment its capabilities in clinical intelligence and quality improvement solutions, fostering improved collaboration between health plans and providers. This will be instrumental in enhancing patient outcomes, regulatory compliance, and financial performance. Through this acquisition, Reveleer is poised to deliver modern, AI-powered solutions aimed at seamless payer-provider collaboration, thereby advancing efforts in risk adjustment and quality improvement. The integration of Novillus technologies will also boost Reveleer’s ability to support compliance amid regulations like the federal No Surprises Act. The acquisition promises immediate benefits for both Reveleer and Novillus customers, offering expanded quality improvement capabilities and access to a comprehensive suite of value-based care solutions. This move culminates a strategic initiative by Reveleer over the past three years to build a robust, value-based care platform, with the combined entity now serving 72 million covered lives and collaborating with 86 leading healthcare organizations across the United States.